

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.22564017 |
| 2 | * Arp2/3 complex-mediated actin nucleation (GO:0034314) | 5.01479503 |
| 3 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.73241356 |
| 4 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.73241356 |
| 5 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.46794311 |
| 6 | leukocyte aggregation (GO:0070486) | 4.29824938 |
| 7 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.27408125 |
| 8 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.19433397 |
| 9 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.03246402 |
| 10 | immunoglobulin mediated immune response (GO:0016064) | 3.96217339 |
| 11 | neutrophil activation involved in immune response (GO:0002283) | 3.95966974 |
| 12 | respiratory burst (GO:0045730) | 3.85619733 |
| 13 | cytidine deamination (GO:0009972) | 3.84308226 |
| 14 | cytidine metabolic process (GO:0046087) | 3.84308226 |
| 15 | cytidine catabolic process (GO:0006216) | 3.84308226 |
| 16 | * actin nucleation (GO:0045010) | 3.63271953 |
| 17 | regulation of T cell tolerance induction (GO:0002664) | 3.60334194 |
| 18 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.49343580 |
| 19 | B cell mediated immunity (GO:0019724) | 3.48783976 |
| 20 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.46792507 |
| 21 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.38868593 |
| 22 | positive regulation by symbiont of host defense response (GO:0052509) | 3.37327876 |
| 23 | modulation by symbiont of host defense response (GO:0052031) | 3.37327876 |
| 24 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.37327876 |
| 25 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.37327876 |
| 26 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.37327876 |
| 27 | modulation by symbiont of host immune response (GO:0052553) | 3.37327876 |
| 28 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.34651899 |
| 29 | T cell costimulation (GO:0031295) | 3.33736952 |
| 30 | regulation of tolerance induction (GO:0002643) | 3.32100225 |
| 31 | lymphocyte costimulation (GO:0031294) | 3.29111157 |
| 32 | positive T cell selection (GO:0043368) | 3.28798131 |
| 33 | detection of other organism (GO:0098543) | 3.25325992 |
| 34 | sequestering of actin monomers (GO:0042989) | 3.24671189 |
| 35 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.24258629 |
| 36 | negative regulation of cell killing (GO:0031342) | 3.24258629 |
| 37 | detection of bacterium (GO:0016045) | 3.23392097 |
| 38 | positive regulation of interferon-alpha production (GO:0032727) | 3.22239136 |
| 39 | response to peptidoglycan (GO:0032494) | 3.19975184 |
| 40 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.18855989 |
| 41 | negative regulation of phagocytosis (GO:0050765) | 3.18377540 |
| 42 | ribosomal small subunit assembly (GO:0000028) | 3.17083323 |
| 43 | cellular extravasation (GO:0045123) | 3.16052262 |
| 44 | negative thymic T cell selection (GO:0045060) | 3.13728815 |
| 45 | * positive regulation of lamellipodium assembly (GO:0010592) | 3.11218170 |
| 46 | pinocytosis (GO:0006907) | 3.11043927 |
| 47 | B cell receptor signaling pathway (GO:0050853) | 3.10839426 |
| 48 | regulation of B cell differentiation (GO:0045577) | 3.09454504 |
| 49 | regulation of interferon-alpha production (GO:0032647) | 3.09394766 |
| 50 | positive regulation of macrophage differentiation (GO:0045651) | 3.08246293 |
| 51 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.07697133 |
| 52 | positive regulation of interleukin-8 secretion (GO:2000484) | 3.07190424 |
| 53 | positive thymic T cell selection (GO:0045059) | 3.06269060 |
| 54 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.05545048 |
| 55 | T cell migration (GO:0072678) | 3.02433122 |
| 56 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.00711252 |
| 57 | negative T cell selection (GO:0043383) | 3.00121079 |
| 58 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.98573210 |
| 59 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.98571531 |
| 60 | positive regulation of tolerance induction (GO:0002645) | 2.95650537 |
| 61 | response to type I interferon (GO:0034340) | 2.94957594 |
| 62 | type I interferon signaling pathway (GO:0060337) | 2.93516736 |
| 63 | cellular response to type I interferon (GO:0071357) | 2.93516736 |
| 64 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.93449522 |
| 65 | T cell selection (GO:0045058) | 2.93355081 |
| 66 | positive regulation of B cell differentiation (GO:0045579) | 2.92379221 |
| 67 | T cell receptor signaling pathway (GO:0050852) | 2.91414272 |
| 68 | hepatocyte apoptotic process (GO:0097284) | 2.90763539 |
| 69 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.90421606 |
| 70 | regulation of mast cell degranulation (GO:0043304) | 2.89190063 |
| 71 | myeloid dendritic cell activation (GO:0001773) | 2.89086828 |
| 72 | neutrophil activation (GO:0042119) | 2.89061157 |
| 73 | response to protozoan (GO:0001562) | 2.88921348 |
| 74 | defense response to protozoan (GO:0042832) | 2.87218467 |
| 75 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.87148231 |
| 76 | NIK/NF-kappaB signaling (GO:0038061) | 2.86520478 |
| 77 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.86217579 |
| 78 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.86217579 |
| 79 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.85646535 |
| 80 | regulation of gamma-delta T cell activation (GO:0046643) | 2.84872660 |
| 81 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.84843956 |
| 82 | leukocyte cell-cell adhesion (GO:0007159) | 2.84155186 |
| 83 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.80714351 |
| 84 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.80547234 |
| 85 | cellular response to interferon-gamma (GO:0071346) | 2.79228857 |
| 86 | barbed-end actin filament capping (GO:0051016) | 2.78470636 |
| 87 | granulocyte activation (GO:0036230) | 2.78403261 |
| 88 | regulation of mast cell activation (GO:0033003) | 2.77931996 |
| 89 | leukocyte degranulation (GO:0043299) | 2.77790929 |
| 90 | cellular response to zinc ion (GO:0071294) | 2.77729838 |
| 91 | mast cell activation (GO:0045576) | 2.77515829 |
| 92 | lymphocyte chemotaxis (GO:0048247) | 2.76653452 |
| 93 | regulation of regulatory T cell differentiation (GO:0045589) | 2.76639792 |
| 94 | positive regulation of lymphocyte migration (GO:2000403) | 2.76265368 |
| 95 | cellular response to interferon-beta (GO:0035458) | 2.75906370 |
| 96 | negative regulation of T cell mediated immunity (GO:0002710) | 2.74062716 |
| 97 | response to interferon-beta (GO:0035456) | 2.73044971 |
| 98 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.72999218 |
| 99 | natural killer cell mediated immunity (GO:0002228) | 2.72999218 |
| 100 | regulation of necroptotic process (GO:0060544) | 2.72202203 |
| 101 | positive regulation of antigen processing and presentation (GO:0002579) | 2.71605800 |
| 102 | interferon-gamma production (GO:0032609) | 2.71212613 |
| 103 | regulation of lymphocyte migration (GO:2000401) | 2.70969209 |
| 104 | myeloid cell activation involved in immune response (GO:0002275) | 2.70528339 |
| 105 | mature B cell differentiation involved in immune response (GO:0002313) | 2.67884418 |
| 106 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.67806408 |
| 107 | positive regulation of mast cell degranulation (GO:0043306) | 2.67806408 |
| 108 | detection of external biotic stimulus (GO:0098581) | 2.66354097 |
| 109 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.63894421 |
| 110 | myeloid dendritic cell differentiation (GO:0043011) | 2.63576464 |
| 111 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.63393940 |
| 112 | * positive regulation of lamellipodium organization (GO:1902745) | 2.63345784 |
| 113 | positive regulation of mast cell activation (GO:0033005) | 2.63099170 |
| 114 | viral transcription (GO:0019083) | 2.62706255 |
| 115 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.62417961 |
| 116 | regulation of response to interferon-gamma (GO:0060330) | 2.60718826 |
| 117 | thymic T cell selection (GO:0045061) | 2.60470573 |
| 118 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.58948025 |
| 119 | response to interleukin-15 (GO:0070672) | 2.58916168 |
| 120 | regulation of protein heterodimerization activity (GO:0043497) | 2.58865329 |
| 121 | positive regulation of isotype switching (GO:0045830) | 2.57633344 |
| 122 | tolerance induction (GO:0002507) | 2.56547603 |
| 123 | T cell apoptotic process (GO:0070231) | 2.54286561 |
| 124 | translational termination (GO:0006415) | 2.53995510 |
| 125 | negative regulation of interleukin-12 production (GO:0032695) | 2.53537838 |
| 126 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.52951324 |
| 127 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.52887583 |
| 128 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.52452804 |
| 129 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.52165179 |
| 130 | cellular response to interleukin-15 (GO:0071350) | 2.48997795 |
| 131 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.48810934 |
| 132 | regulation of antigen processing and presentation (GO:0002577) | 2.45950470 |
| 133 | response to muramyl dipeptide (GO:0032495) | 2.45824456 |
| 134 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.44675933 |
| 135 | macrophage activation involved in immune response (GO:0002281) | 2.44106038 |
| 136 | leukocyte mediated cytotoxicity (GO:0001909) | 2.42913725 |
| 137 | lymphocyte mediated immunity (GO:0002449) | 2.41914118 |
| 138 | DNA deamination (GO:0045006) | 2.41753063 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.17341116 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.06404863 |
| 3 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.88278999 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.34744103 |
| 5 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.22839263 |
| 6 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.22391195 |
| 7 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.07262573 |
| 8 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.03208720 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.00507021 |
| 10 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.94255006 |
| 11 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.84352309 |
| 12 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.76600449 |
| 13 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.69787647 |
| 14 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.65261991 |
| 15 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.57326054 |
| 16 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.56426098 |
| 17 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.54364934 |
| 18 | MYC_22102868_ChIP-Seq_BL_Human | 2.44317874 |
| 19 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.38412676 |
| 20 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.37970061 |
| 21 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.27993085 |
| 22 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.26406382 |
| 23 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.25589057 |
| 24 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.24310311 |
| 25 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.22669709 |
| 26 | * MYB_26560356_Chip-Seq_TH2_Human | 2.17309774 |
| 27 | MAF_26560356_Chip-Seq_TH1_Human | 2.12393028 |
| 28 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.09751814 |
| 29 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.06686089 |
| 30 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.03626408 |
| 31 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.00514714 |
| 32 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.00463781 |
| 33 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.91443117 |
| 34 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.91262621 |
| 35 | MYB_26560356_Chip-Seq_TH1_Human | 1.86341780 |
| 36 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.81305145 |
| 37 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.80720035 |
| 38 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.77005820 |
| 39 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.76032692 |
| 40 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.75023869 |
| 41 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.74769394 |
| 42 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.73527320 |
| 43 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.68334331 |
| 44 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.55385648 |
| 45 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.54420512 |
| 46 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52591197 |
| 47 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.51330442 |
| 48 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.50922792 |
| 49 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.37578541 |
| 50 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.37567666 |
| 51 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.37141503 |
| 52 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.36489096 |
| 53 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.36472986 |
| 54 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.36366996 |
| 55 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.35296597 |
| 56 | * E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.35155821 |
| 57 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.35143649 |
| 58 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.32782981 |
| 59 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.32320275 |
| 60 | MAF_26560356_Chip-Seq_TH2_Human | 1.31293865 |
| 61 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.28685721 |
| 62 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.27832808 |
| 63 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.27776759 |
| 64 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.26244016 |
| 65 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.25177940 |
| 66 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.23830813 |
| 67 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.22599302 |
| 68 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.22438850 |
| 69 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.22230267 |
| 70 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.21675592 |
| 71 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.17055204 |
| 72 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.15692914 |
| 73 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.15186320 |
| 74 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.14339077 |
| 75 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.13220849 |
| 76 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.12045035 |
| 77 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.09072579 |
| 78 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.09030655 |
| 79 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.07418925 |
| 80 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.07180710 |
| 81 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.05380283 |
| 82 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.03127611 |
| 83 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.02589087 |
| 84 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.02416530 |
| 85 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.01914765 |
| 86 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.01764707 |
| 87 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.01482940 |
| 88 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00762683 |
| 89 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.00756992 |
| 90 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00655479 |
| 91 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.00618464 |
| 92 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00496154 |
| 93 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.00323196 |
| 94 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.00181118 |
| 95 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99611861 |
| 96 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.99344158 |
| 97 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.99027622 |
| 98 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.97314735 |
| 99 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.97059984 |
| 100 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.95978862 |
| 101 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.95853076 |
| 102 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.95193681 |
| 103 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95101022 |
| 104 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.95019068 |
| 105 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.92740915 |
| 106 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.92651023 |
| 107 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.91653521 |
| 108 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.88721285 |
| 109 | * GATA3_26560356_Chip-Seq_TH2_Human | 0.88380187 |
| 110 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.88303046 |
| 111 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.87883778 |
| 112 | GATA1_22025678_ChIP-Seq_K562_Human | 0.87756494 |
| 113 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.86953787 |
| 114 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.84834889 |
| 115 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.84785318 |
| 116 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.84079813 |
| 117 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.83623934 |
| 118 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.83569795 |
| 119 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.81296359 |
| 120 | P300_27268052_Chip-Seq_Bcells_Human | 0.78453539 |
| 121 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.77892440 |
| 122 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.76886278 |
| 123 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.74442641 |
| 124 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.73865703 |
| 125 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.73072090 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.03716325 |
| 2 | MP0003436_decreased_susceptibility_to | 3.40148540 |
| 3 | MP0003303_peritoneal_inflammation | 3.35275865 |
| 4 | MP0000685_abnormal_immune_system | 3.06785318 |
| 5 | MP0009785_altered_susceptibility_to | 3.00569074 |
| 6 | MP0005671_abnormal_response_to | 2.96490983 |
| 7 | MP0005000_abnormal_immune_tolerance | 2.79938959 |
| 8 | MP0002148_abnormal_hypersensitivity_rea | 2.69189880 |
| 9 | MP0005025_abnormal_response_to | 2.62952402 |
| 10 | MP0001800_abnormal_humoral_immune | 2.62704174 |
| 11 | MP0002452_abnormal_antigen_presenting | 2.60317124 |
| 12 | MP0002419_abnormal_innate_immunity | 2.55005879 |
| 13 | MP0001790_abnormal_immune_system | 2.54459720 |
| 14 | MP0005387_immune_system_phenotype | 2.54459720 |
| 15 | MP0001819_abnormal_immune_cell | 2.41834276 |
| 16 | MP0002420_abnormal_adaptive_immunity | 2.41806857 |
| 17 | MP0002723_abnormal_immune_serum | 2.41019031 |
| 18 | MP0003763_abnormal_thymus_physiology | 2.38324604 |
| 19 | MP0003724_increased_susceptibility_to | 2.33746796 |
| 20 | MP0006082_CNS_inflammation | 2.32002587 |
| 21 | MP0002396_abnormal_hematopoietic_system | 2.17558796 |
| 22 | MP0002398_abnormal_bone_marrow | 2.11687287 |
| 23 | MP0003300_gastrointestinal_ulcer | 2.10421695 |
| 24 | MP0002405_respiratory_system_inflammati | 2.10177797 |
| 25 | MP0005464_abnormal_platelet_physiology | 2.09109986 |
| 26 | MP0009333_abnormal_splenocyte_physiolog | 2.07818453 |
| 27 | MP0002166_altered_tumor_susceptibility | 2.07042827 |
| 28 | MP0003806_abnormal_nucleotide_metabolis | 1.98619016 |
| 29 | MP0000716_abnormal_immune_system | 1.94776164 |
| 30 | MP0005058_abnormal_lysosome_morphology | 1.90401301 |
| 31 | MP0010155_abnormal_intestine_physiology | 1.90309918 |
| 32 | MP0001853_heart_inflammation | 1.90153671 |
| 33 | MP0005397_hematopoietic_system_phenotyp | 1.81055733 |
| 34 | MP0001545_abnormal_hematopoietic_system | 1.81055733 |
| 35 | MP0001533_abnormal_skeleton_physiology | 1.80920686 |
| 36 | MP0002006_tumorigenesis | 1.80001248 |
| 37 | MP0010352_gastrointestinal_tract_polyps | 1.78298891 |
| 38 | MP0000689_abnormal_spleen_morphology | 1.77759136 |
| 39 | MP0000858_altered_metastatic_potential | 1.75554345 |
| 40 | MP0002722_abnormal_immune_system | 1.74207177 |
| 41 | MP0001845_abnormal_inflammatory_respons | 1.72766307 |
| 42 | MP0004510_myositis | 1.72468265 |
| 43 | MP0004808_abnormal_hematopoietic_stem | 1.71378504 |
| 44 | MP0004947_skin_inflammation | 1.70528024 |
| 45 | MP0002429_abnormal_blood_cell | 1.68141604 |
| 46 | MP0000490_abnormal_crypts_of | 1.63002392 |
| 47 | MP0003448_altered_tumor_morphology | 1.51134508 |
| 48 | MP0003693_abnormal_embryo_hatching | 1.49768838 |
| 49 | MP0009278_abnormal_bone_marrow | 1.47587162 |
| 50 | MP0000343_altered_response_to | 1.45354319 |
| 51 | MP0001873_stomach_inflammation | 1.41457564 |
| 52 | MP0000703_abnormal_thymus_morphology | 1.38105874 |
| 53 | MP0003866_abnormal_defecation | 1.37365957 |
| 54 | MP0000465_gastrointestinal_hemorrhage | 1.37140684 |
| 55 | MP0002933_joint_inflammation | 1.35446689 |
| 56 | MP0008469_abnormal_protein_level | 1.32766231 |
| 57 | MP0003566_abnormal_cell_adhesion | 1.32294320 |
| 58 | MP0008260_abnormal_autophagy | 1.31657923 |
| 59 | MP0003172_abnormal_lysosome_physiology | 1.20949893 |
| 60 | MP0005451_abnormal_body_composition | 1.20537257 |
| 61 | MP0006054_spinal_hemorrhage | 1.17886393 |
| 62 | MP0005310_abnormal_salivary_gland | 1.16646707 |
| 63 | MP0003828_pulmonary_edema | 1.12076644 |
| 64 | MP0005023_abnormal_wound_healing | 1.10943732 |
| 65 | MP0002138_abnormal_hepatobiliary_system | 1.09018301 |
| 66 | MP0009764_decreased_sensitivity_to | 1.08628654 |
| 67 | MP0005174_abnormal_tail_pigmentation | 1.08094466 |
| 68 | MP0005076_abnormal_cell_differentiation | 1.08021280 |
| 69 | MP0010307_abnormal_tumor_latency | 1.07614702 |
| 70 | MP0004957_abnormal_blastocyst_morpholog | 1.06377664 |
| 71 | MP0002019_abnormal_tumor_incidence | 1.04341709 |
| 72 | MP0005166_decreased_susceptibility_to | 1.03463051 |
| 73 | MP0001542_abnormal_bone_strength | 1.01319714 |
| 74 | MP0001851_eye_inflammation | 1.01153999 |
| 75 | MP0005075_abnormal_melanosome_morpholog | 1.00462301 |
| 76 | MP0002998_abnormal_bone_remodeling | 0.96303357 |
| 77 | MP0003075_altered_response_to | 0.95747268 |
| 78 | MP0008007_abnormal_cellular_replicative | 0.95724129 |
| 79 | MP0003191_abnormal_cellular_cholesterol | 0.91335428 |
| 80 | MP0002877_abnormal_melanocyte_morpholog | 0.90582374 |
| 81 | MP0005390_skeleton_phenotype | 0.88067866 |
| 82 | MP0004883_abnormal_blood_vessel | 0.84758661 |
| 83 | MP0003183_abnormal_peptide_metabolism | 0.84688213 |
| 84 | MP0003077_abnormal_cell_cycle | 0.82965317 |
| 85 | MP0009840_abnormal_foam_cell | 0.80923672 |
| 86 | MP0003045_fibrosis | 0.80722574 |
| 87 | MP0000015_abnormal_ear_pigmentation | 0.78493187 |
| 88 | MP0003705_abnormal_hypodermis_morpholog | 0.76456578 |
| 89 | MP0003453_abnormal_keratinocyte_physiol | 0.74703923 |
| 90 | MP0005165_increased_susceptibility_to | 0.74474397 |
| 91 | MP0009763_increased_sensitivity_to | 0.74341941 |
| 92 | MP0003795_abnormal_bone_structure | 0.72921332 |
| 93 | MP0009765_abnormal_xenobiotic_induced | 0.72867760 |
| 94 | MP0002277_abnormal_respiratory_mucosa | 0.72809021 |
| 95 | MP0000249_abnormal_blood_vessel | 0.72772391 |
| 96 | MP0001663_abnormal_digestive_system | 0.70610430 |
| 97 | MP0010234_abnormal_vibrissa_follicle | 0.69394186 |
| 98 | MP0000604_amyloidosis | 0.68189499 |
| 99 | MP0003111_abnormal_nucleus_morphology | 0.67099202 |
| 100 | MP0003279_aneurysm | 0.67008307 |
| 101 | MP0003091_abnormal_cell_migration | 0.66499638 |
| 102 | MP0000313_abnormal_cell_death | 0.65807008 |
| 103 | MP0010094_abnormal_chromosome_stability | 0.65525043 |
| 104 | MP0003186_abnormal_redox_activity | 0.64872386 |
| 105 | MP0001958_emphysema | 0.64519454 |
| 106 | MP0000477_abnormal_intestine_morphology | 0.64065875 |
| 107 | MP0005084_abnormal_gallbladder_morpholo | 0.63192546 |
| 108 | MP0004381_abnormal_hair_follicle | 0.60798916 |
| 109 | MP0008004_abnormal_stomach_pH | 0.60370120 |
| 110 | MP0005164_abnormal_response_to | 0.59928770 |
| 111 | MP0002136_abnormal_kidney_physiology | 0.59163605 |
| 112 | MP0002132_abnormal_respiratory_system | 0.58845483 |
| 113 | MP0001243_abnormal_dermal_layer | 0.54306368 |
| 114 | MP0003950_abnormal_plasma_membrane | 0.53676421 |
| 115 | MP0005319_abnormal_enzyme/_coenzyme | 0.53593745 |
| 116 | MP0008873_increased_physiological_sensi | 0.52618646 |
| 117 | MP0006036_abnormal_mitochondrial_physio | 0.52348894 |
| 118 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.51772734 |
| 119 | MP0003786_premature_aging | 0.51228186 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 6.41989562 |
| 2 | Recurrent abscess formation (HP:0002722) | 5.74070623 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 5.05330969 |
| 4 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.59077791 |
| 5 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.22944760 |
| 6 | Myositis (HP:0100614) | 4.16137451 |
| 7 | Abnormality of macrophages (HP:0004311) | 4.02858318 |
| 8 | Obstructive lung disease (HP:0006536) | 3.92364698 |
| 9 | Chronic obstructive pulmonary disease (HP:0006510) | 3.92364698 |
| 10 | Recurrent fungal infections (HP:0002841) | 3.92004126 |
| 11 | Vacuolated lymphocytes (HP:0001922) | 3.89330687 |
| 12 | Mediastinal lymphadenopathy (HP:0100721) | 3.72755579 |
| 13 | IgM deficiency (HP:0002850) | 3.54540879 |
| 14 | Chronic otitis media (HP:0000389) | 3.48933744 |
| 15 | Autoimmune hemolytic anemia (HP:0001890) | 3.41167370 |
| 16 | Thrombocytosis (HP:0001894) | 3.33130897 |
| 17 | Recurrent skin infections (HP:0001581) | 3.31197146 |
| 18 | Recurrent viral infections (HP:0004429) | 3.29362832 |
| 19 | Stomatitis (HP:0010280) | 3.26379472 |
| 20 | Cellulitis (HP:0100658) | 3.23996686 |
| 21 | Recurrent bronchitis (HP:0002837) | 3.13110061 |
| 22 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.09268183 |
| 23 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.09268183 |
| 24 | Abnormality of glycolipid metabolism (HP:0010969) | 3.09268183 |
| 25 | Gingivitis (HP:0000230) | 3.07524771 |
| 26 | Orchitis (HP:0100796) | 3.06615553 |
| 27 | Increased cerebral lipofuscin (HP:0011813) | 3.04654002 |
| 28 | Meningitis (HP:0001287) | 3.03073083 |
| 29 | Petechiae (HP:0000967) | 3.01631504 |
| 30 | Spontaneous hematomas (HP:0007420) | 2.99159998 |
| 31 | Abnormality of T cell physiology (HP:0011840) | 2.98197027 |
| 32 | Abnormality of T cells (HP:0002843) | 2.95919520 |
| 33 | Pustule (HP:0200039) | 2.95717863 |
| 34 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.91280834 |
| 35 | Interstitial pulmonary disease (HP:0006530) | 2.85271719 |
| 36 | Autoimmune thrombocytopenia (HP:0001973) | 2.84364893 |
| 37 | Vasculitis (HP:0002633) | 2.81526777 |
| 38 | Recurrent cutaneous fungal infections (HP:0011370) | 2.79018098 |
| 39 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.79018098 |
| 40 | Chronic diarrhea (HP:0002028) | 2.75840908 |
| 41 | Retrobulbar optic neuritis (HP:0100654) | 2.65813172 |
| 42 | Optic neuritis (HP:0100653) | 2.65813172 |
| 43 | Abnormality of T cell number (HP:0011839) | 2.64944030 |
| 44 | Abnormality of the nasal mucosa (HP:0000433) | 2.61201251 |
| 45 | Nasal polyposis (HP:0100582) | 2.61177307 |
| 46 | T lymphocytopenia (HP:0005403) | 2.58829414 |
| 47 | Panhypogammaglobulinemia (HP:0003139) | 2.55233877 |
| 48 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.54413104 |
| 49 | Dysostosis multiplex (HP:0000943) | 2.53856195 |
| 50 | Lymphopenia (HP:0001888) | 2.53220496 |
| 51 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.53014792 |
| 52 | Urticaria (HP:0001025) | 2.52540290 |
| 53 | Increased IgM level (HP:0003496) | 2.51488598 |
| 54 | Skin rash (HP:0000988) | 2.49070723 |
| 55 | Hypergammaglobulinemia (HP:0010702) | 2.47050782 |
| 56 | IgG deficiency (HP:0004315) | 2.45909628 |
| 57 | Gangrene (HP:0100758) | 2.45472275 |
| 58 | Basal ganglia calcification (HP:0002135) | 2.44663697 |
| 59 | Hepatosplenomegaly (HP:0001433) | 2.42925524 |
| 60 | Severe combined immunodeficiency (HP:0004430) | 2.42671753 |
| 61 | Leukocytosis (HP:0001974) | 2.40421685 |
| 62 | Periodontitis (HP:0000704) | 2.36783107 |
| 63 | Arterial thrombosis (HP:0004420) | 2.36621497 |
| 64 | Keratoconjunctivitis (HP:0001096) | 2.35343853 |
| 65 | Abnormality of the pleura (HP:0002103) | 2.34635805 |
| 66 | Prolonged bleeding time (HP:0003010) | 2.33220170 |
| 67 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.33035544 |
| 68 | Gingival bleeding (HP:0000225) | 2.32537650 |
| 69 | Disinhibition (HP:0000734) | 2.32367549 |
| 70 | Combined immunodeficiency (HP:0005387) | 2.31725742 |
| 71 | Glomerulopathy (HP:0100820) | 2.31145092 |
| 72 | Inflammation of the large intestine (HP:0002037) | 2.28589528 |
| 73 | Osteomyelitis (HP:0002754) | 2.28426278 |
| 74 | Increased IgE level (HP:0003212) | 2.28172582 |
| 75 | Gastrointestinal inflammation (HP:0004386) | 2.26690211 |
| 76 | Pulmonary fibrosis (HP:0002206) | 2.22757591 |
| 77 | Chest pain (HP:0100749) | 2.22507624 |
| 78 | Hemoptysis (HP:0002105) | 2.21846319 |
| 79 | Purpura (HP:0000979) | 2.21659495 |
| 80 | Hematochezia (HP:0002573) | 2.20005897 |
| 81 | Acute hepatic failure (HP:0006554) | 2.18852822 |
| 82 | Poor head control (HP:0002421) | 2.18257402 |
| 83 | Pulmonary infiltrates (HP:0002113) | 2.17455412 |
| 84 | Hypoproteinemia (HP:0003075) | 2.14383808 |
| 85 | Recurrent pneumonia (HP:0006532) | 2.13879964 |
| 86 | Anorexia (HP:0002039) | 2.13834425 |
| 87 | Skin ulcer (HP:0200042) | 2.13322443 |
| 88 | Agammaglobulinemia (HP:0004432) | 2.12418521 |
| 89 | Joint swelling (HP:0001386) | 2.11395881 |
| 90 | Encephalitis (HP:0002383) | 2.11153670 |
| 91 | Recurrent lower respiratory tract infections (HP:0002783) | 2.10313743 |
| 92 | Pulmonary embolism (HP:0002204) | 2.09616762 |
| 93 | Abnormal platelet volume (HP:0011876) | 2.07835294 |
| 94 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.07352143 |
| 95 | Mucopolysacchariduria (HP:0008155) | 2.07352143 |
| 96 | Epistaxis (HP:0000421) | 2.06574770 |
| 97 | Amaurosis fugax (HP:0100576) | 2.06378451 |
| 98 | Eosinophilia (HP:0001880) | 2.05978146 |
| 99 | Granulocytopenia (HP:0001913) | 2.05864204 |
| 100 | Impaired platelet aggregation (HP:0003540) | 2.05225916 |
| 101 | Abnormal platelet function (HP:0011869) | 2.05225916 |
| 102 | Verrucae (HP:0200043) | 2.05150945 |
| 103 | Papilloma (HP:0012740) | 2.05150945 |
| 104 | Systemic lupus erythematosus (HP:0002725) | 2.05067116 |
| 105 | Abnormality of the prostate (HP:0008775) | 2.02060463 |
| 106 | Polyneuropathy (HP:0001271) | 2.01144763 |
| 107 | Increased density of long bones (HP:0006392) | 2.00200127 |
| 108 | Abnormality of eosinophils (HP:0001879) | 1.98389950 |
| 109 | Agnosia (HP:0010524) | 1.96523315 |
| 110 | Lymphoma (HP:0002665) | 1.96501324 |
| 111 | Abnormality of the pericardium (HP:0001697) | 1.96343197 |
| 112 | Aplastic anemia (HP:0001915) | 1.95395568 |
| 113 | Increased serum ferritin (HP:0003281) | 1.94379780 |
| 114 | Sepsis (HP:0100806) | 1.94007534 |
| 115 | IgA deficiency (HP:0002720) | 1.93320165 |
| 116 | Vertebral compression fractures (HP:0002953) | 1.93209814 |
| 117 | Premature loss of primary teeth (HP:0006323) | 1.92128305 |
| 118 | Hypertensive crisis (HP:0100735) | 1.91969322 |
| 119 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.90841821 |
| 120 | Gastrointestinal infarctions (HP:0005244) | 1.90111401 |
| 121 | Keratoconjunctivitis sicca (HP:0001097) | 1.90103068 |
| 122 | Emphysema (HP:0002097) | 1.89452306 |
| 123 | Spondylolisthesis (HP:0003302) | 1.89327463 |
| 124 | Diminished motivation (HP:0000745) | 1.87725542 |
| 125 | Gastrointestinal stroma tumor (HP:0100723) | 1.87471175 |
| 126 | Abnormality of B cell number (HP:0010975) | 1.87338817 |
| 127 | B lymphocytopenia (HP:0010976) | 1.87338817 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 3.96218164 |
| 2 | BLK | 3.22175380 |
| 3 | KDR | 2.73197124 |
| 4 | PIM2 | 2.70598480 |
| 5 | NME2 | 2.64240402 |
| 6 | ZAP70 | 2.54736481 |
| 7 | TESK2 | 2.52583402 |
| 8 | TXK | 2.39886631 |
| 9 | IRAK4 | 2.36497363 |
| 10 | RIPK4 | 2.31794330 |
| 11 | TBK1 | 2.28652868 |
| 12 | JAK3 | 2.05753658 |
| 13 | KIT | 2.04241026 |
| 14 | TESK1 | 1.98757471 |
| 15 | TRIB3 | 1.96308361 |
| 16 | TYK2 | 1.95295219 |
| 17 | ERN1 | 1.93294741 |
| 18 | BTK | 1.85468309 |
| 19 | BMPR2 | 1.83391539 |
| 20 | MAP3K14 | 1.80386034 |
| 21 | TEC | 1.78226010 |
| 22 | STK10 | 1.76725925 |
| 23 | MAP3K12 | 1.74225122 |
| 24 | EIF2AK1 | 1.73987374 |
| 25 | BCKDK | 1.64385158 |
| 26 | RPS6KA4 | 1.59035328 |
| 27 | LRRK2 | 1.58837588 |
| 28 | IKBKE | 1.53850485 |
| 29 | PKN2 | 1.52853222 |
| 30 | SYK | 1.50784112 |
| 31 | SCYL2 | 1.49586061 |
| 32 | CSF1R | 1.39761226 |
| 33 | CSK | 1.39277436 |
| 34 | NEK9 | 1.35230153 |
| 35 | GRK7 | 1.35209698 |
| 36 | MAP2K3 | 1.31469043 |
| 37 | MAP3K11 | 1.30219682 |
| 38 | ITK | 1.29972960 |
| 39 | IKBKB | 1.21908390 |
| 40 | LCK | 1.19926117 |
| 41 | GRK6 | 1.17437769 |
| 42 | PIK3CG | 1.17175244 |
| 43 | HCK | 1.17064129 |
| 44 | LYN | 1.11350776 |
| 45 | PIM1 | 1.11010677 |
| 46 | PAK4 | 1.08985218 |
| 47 | JAK1 | 1.02610029 |
| 48 | FES | 0.96412460 |
| 49 | ARAF | 0.96314666 |
| 50 | TGFBR2 | 0.96241532 |
| 51 | EIF2AK3 | 0.96150230 |
| 52 | IRAK3 | 0.96080282 |
| 53 | CDK19 | 0.94327675 |
| 54 | VRK2 | 0.89173911 |
| 55 | ACVR1B | 0.86390731 |
| 56 | TNK2 | 0.82831885 |
| 57 | MAP3K10 | 0.82812483 |
| 58 | TAOK3 | 0.82257089 |
| 59 | TGFBR1 | 0.80463163 |
| 60 | FLT3 | 0.80141847 |
| 61 | TAOK2 | 0.79074763 |
| 62 | MARK3 | 0.78908010 |
| 63 | NLK | 0.78869535 |
| 64 | EEF2K | 0.78046493 |
| 65 | PRPF4B | 0.76790842 |
| 66 | ILK | 0.76328618 |
| 67 | MAP3K13 | 0.75786608 |
| 68 | CDK6 | 0.74910697 |
| 69 | NEK2 | 0.74848469 |
| 70 | FGFR4 | 0.73264106 |
| 71 | WEE1 | 0.73212032 |
| 72 | MAP3K5 | 0.73002410 |
| 73 | MAP3K8 | 0.71590731 |
| 74 | MST4 | 0.70078849 |
| 75 | CLK1 | 0.67862421 |
| 76 | MOS | 0.66785145 |
| 77 | CHUK | 0.64787925 |
| 78 | MATK | 0.64113024 |
| 79 | MAP3K3 | 0.63368012 |
| 80 | LIMK1 | 0.62457429 |
| 81 | JAK2 | 0.61875412 |
| 82 | BUB1 | 0.61149991 |
| 83 | MAPKAPK3 | 0.61025420 |
| 84 | ABL2 | 0.61008054 |
| 85 | NUAK1 | 0.59396507 |
| 86 | FGFR3 | 0.57382541 |
| 87 | RAF1 | 0.56249057 |
| 88 | MAPKAPK2 | 0.54894518 |
| 89 | RIPK1 | 0.53053461 |
| 90 | TTN | 0.52633233 |
| 91 | DYRK1B | 0.51851594 |
| 92 | FYN | 0.50376735 |
| 93 | CDK4 | 0.49658085 |
| 94 | STK4 | 0.47419656 |
| 95 | PRKG2 | 0.47179089 |
| 96 | PTK6 | 0.46894661 |
| 97 | ABL1 | 0.46648841 |
| 98 | DMPK | 0.45096609 |
| 99 | PDK1 | 0.44280690 |
| 100 | EPHB1 | 0.43782564 |
| 101 | TAOK1 | 0.43695820 |
| 102 | CAMKK2 | 0.43353755 |
| 103 | PRKCD | 0.43031136 |
| 104 | RPS6KB2 | 0.42949231 |
| 105 | MAP3K1 | 0.42402937 |
| 106 | ADRBK2 | 0.42199186 |
| 107 | DAPK1 | 0.39937637 |
| 108 | ALK | 0.39487452 |
| 109 | PRKCQ | 0.39149357 |
| 110 | EGFR | 0.39074347 |
| 111 | IGF1R | 0.38532989 |
| 112 | TRPM7 | 0.38319843 |
| 113 | PAK1 | 0.38237845 |
| 114 | MAP2K6 | 0.38069364 |
| 115 | DAPK3 | 0.37541952 |
| 116 | MAPK11 | 0.36787934 |
| 117 | SIK3 | 0.33957945 |
| 118 | FGR | 0.33217723 |
| 119 | CDC7 | 0.32697457 |
| 120 | MYLK | 0.32135787 |
| 121 | AURKB | 0.31078428 |
| 122 | MAP4K2 | 0.30243110 |
| 123 | INSR | 0.26510277 |
| 124 | PTK2B | 0.25501901 |
| 125 | TLK1 | 0.22078173 |
| 126 | MAPK12 | 0.19109308 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 2.83174938 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.74589743 |
| 3 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.20732723 |
| 4 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.05514986 |
| 5 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.00848664 |
| 6 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.00312976 |
| 7 | Measles_Homo sapiens_hsa05162 | 1.94726882 |
| 8 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.94486100 |
| 9 | * Shigellosis_Homo sapiens_hsa05131 | 1.93562957 |
| 10 | Legionellosis_Homo sapiens_hsa05134 | 1.91310727 |
| 11 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.87206619 |
| 12 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.86189900 |
| 13 | DNA replication_Homo sapiens_hsa03030 | 1.85559231 |
| 14 | Ribosome_Homo sapiens_hsa03010 | 1.83032048 |
| 15 | Allograft rejection_Homo sapiens_hsa05330 | 1.80118489 |
| 16 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.79777094 |
| 17 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.77063335 |
| 18 | Pertussis_Homo sapiens_hsa05133 | 1.72644947 |
| 19 | Proteasome_Homo sapiens_hsa03050 | 1.69880706 |
| 20 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.69156121 |
| 21 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.68815389 |
| 22 | * Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.62961846 |
| 23 | Tuberculosis_Homo sapiens_hsa05152 | 1.62328205 |
| 24 | Viral myocarditis_Homo sapiens_hsa05416 | 1.61601554 |
| 25 | * Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.60579095 |
| 26 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.55357832 |
| 27 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.55057042 |
| 28 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.54080210 |
| 29 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.51553969 |
| 30 | Other glycan degradation_Homo sapiens_hsa00511 | 1.51374699 |
| 31 | * Salmonella infection_Homo sapiens_hsa05132 | 1.49629035 |
| 32 | Asthma_Homo sapiens_hsa05310 | 1.45860854 |
| 33 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.45213445 |
| 34 | Apoptosis_Homo sapiens_hsa04210 | 1.41932361 |
| 35 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.41165483 |
| 36 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.40436846 |
| 37 | Malaria_Homo sapiens_hsa05144 | 1.37707752 |
| 38 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.33872454 |
| 39 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.32088924 |
| 40 | Hepatitis B_Homo sapiens_hsa05161 | 1.30818594 |
| 41 | Influenza A_Homo sapiens_hsa05164 | 1.29730239 |
| 42 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.29704343 |
| 43 | * Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.29399021 |
| 44 | Lysosome_Homo sapiens_hsa04142 | 1.29165226 |
| 45 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.23652100 |
| 46 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.21913930 |
| 47 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.17214253 |
| 48 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.15032245 |
| 49 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.14573074 |
| 50 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.13534230 |
| 51 | Platelet activation_Homo sapiens_hsa04611 | 1.11821117 |
| 52 | Base excision repair_Homo sapiens_hsa03410 | 1.11475476 |
| 53 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.07705793 |
| 54 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.03501064 |
| 55 | Mismatch repair_Homo sapiens_hsa03430 | 1.03087224 |
| 56 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.01252560 |
| 57 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.01057746 |
| 58 | Phagosome_Homo sapiens_hsa04145 | 0.99753816 |
| 59 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.99205227 |
| 60 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.96491992 |
| 61 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.94811727 |
| 62 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.92062249 |
| 63 | Spliceosome_Homo sapiens_hsa03040 | 0.86937987 |
| 64 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.83585013 |
| 65 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.82425098 |
| 66 | HTLV-I infection_Homo sapiens_hsa05166 | 0.82096624 |
| 67 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.81831481 |
| 68 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.78250111 |
| 69 | Hepatitis C_Homo sapiens_hsa05160 | 0.74702399 |
| 70 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.72865995 |
| 71 | Cell cycle_Homo sapiens_hsa04110 | 0.72422621 |
| 72 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.72325316 |
| 73 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.71592478 |
| 74 | Homologous recombination_Homo sapiens_hsa03440 | 0.71506937 |
| 75 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.71222225 |
| 76 | Parkinsons disease_Homo sapiens_hsa05012 | 0.68457120 |
| 77 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.67231917 |
| 78 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.65782531 |
| 79 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.63865812 |
| 80 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.62603038 |
| 81 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.60655865 |
| 82 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.59335427 |
| 83 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.59312978 |
| 84 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.58695754 |
| 85 | Thyroid cancer_Homo sapiens_hsa05216 | 0.58361554 |
| 86 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.57915016 |
| 87 | * Endocytosis_Homo sapiens_hsa04144 | 0.57413195 |
| 88 | * Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.56134763 |
| 89 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.53886876 |
| 90 | Amoebiasis_Homo sapiens_hsa05146 | 0.53246032 |
| 91 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.52432574 |
| 92 | RNA transport_Homo sapiens_hsa03013 | 0.52299723 |
| 93 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.52002198 |
| 94 | Colorectal cancer_Homo sapiens_hsa05210 | 0.50907119 |
| 95 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.48491271 |
| 96 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.47279249 |
| 97 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.47188781 |
| 98 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.47163075 |
| 99 | Adherens junction_Homo sapiens_hsa04520 | 0.42387176 |
| 100 | Bladder cancer_Homo sapiens_hsa05219 | 0.41468054 |
| 101 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.40763039 |
| 102 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.39876842 |
| 103 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.39251825 |
| 104 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.38905255 |
| 105 | Protein export_Homo sapiens_hsa03060 | 0.37792168 |
| 106 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.36692605 |
| 107 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.36353430 |
| 108 | Focal adhesion_Homo sapiens_hsa04510 | 0.33505413 |
| 109 | Alzheimers disease_Homo sapiens_hsa05010 | 0.33323627 |
| 110 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.32599759 |
| 111 | Galactose metabolism_Homo sapiens_hsa00052 | 0.32232992 |
| 112 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.26740160 |
| 113 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.24547565 |
| 114 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.22197967 |
| 115 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.16940546 |
| 116 | Huntingtons disease_Homo sapiens_hsa05016 | 0.13926335 |
| 117 | RNA polymerase_Homo sapiens_hsa03020 | 0.13286139 |
| 118 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.13284978 |
| 119 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.12190762 |
| 120 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.06696102 |

